ArticleRheumatology (Oxford, England)2011

Comment on: Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR).

Richard Conway et al.PubMed ↗Publisher ↗

No numbers read from the abstract.